Overview

IV Versus IM Administration of Oxytocin for Postpartum Bleeding

Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
This double-blind, randomized controlled trial will evaluate the effect of the route of administration of 10 IU of oxytocin on the average blood loss postpartum. Participants will be randomized to receive 10 IU of oxytocin by IV infusion or 10 IU of oxytocin by injection IM
Phase:
Phase 4
Details
Lead Sponsor:
Gynuity Health Projects
Collaborator:
Centro Rosarino de Estudios Perinatales (CREP)
Treatments:
Oxytocin